“…Two studies each explored the survival outcome of patients with BLCA [ 36 , 63 ], COAD [ 39 , 49 ], LIHC [ 34 , 42 ], THCA [ 44 , 53 ], STAD [ 45 , 47 ], and SKCM [ 38 , 40 ]. Only one study each reported the survival outcome of non-small cell lung cancer (NSCLC) [ 35 ], CESC [ 66 ], KIRC [ 33 ], SARC [ 41 ], READ [ 48 ], COADREAD [ 58 ], PAAD [ 52 ], and UCEC [ 65 ]. Thirty-two of the included studies reported the correlation between LAG3 expression and OS [ 24 – 35 , 37 , 38 , 40 , 42 , 44 – 47 , 50 , 51 , 54 – 59 , 62 – 64 , 66 ], fourteen reported the correlation LAG3 expression and DFS [ 24 – 26 , 33 , 34 , 39 , 42 , 43 , 45 , 46 , 48 , 49 , 52 , 60 ], ten reported the correlation between LAG3 expression and PFS [ 37 , 38 , 41 , 47 , 50 , 61 – 64 , 66 ], and eight reported the correlation between LAG3 expression and RFS [ 27 , 31 , 35 , 36 , 53 ...…”